Akorn lays out $45M for Sunovion lung drug; Sanofi teams with Indian hospitals on diabetes clinics;

> Sunovion Pharmaceuticals said it would sell off rights to its respiratory drug Xoponex (levalbuterol) to Akorn ($AKRX) for $45 million. Release

> Sanofi ($SNY) teamed up with India's Apollo Hospitals on a diabetes-care program in India, delivered through a network of Apollo Sugar Clinics. Report

> Merck Serono tapped Hutchison China MediTech to market its beta blocker Ziac (bisoprolol HCl) in China. Report

> Pfizer Canada and WestJet launched a social media contest to raise awareness of anaphylaxis; Pfizer ($PFE) markets EpiPen in that country. Release

And Finally... Novo Nordisk ($NVO) and Diabetes UK started an awareness campaign, "Talk Hypos," to encourage diabetes patients to report hypoglycemia to their doctor or nurse. Release

Suggested Articles

FDA researchers uncover more concerns and fears among front-line workers and minority groups about a COVID-19 vaccine.

Provention Bio wants to connect the familial threads around Type 1 diabetes with two new campaigns—one targeted at doctors and the other at consumers.

Novartis’ latest campaign with a celebrity dance partner asks people to bust a move to raise awareness around sickle cell anemia and therapy Adakveo.